Research and Markets: Respiratory Hypersensitivity - Active Pharmaceutical ...
Respiratory Hypersensitivity-API Insights, 2015 report provides Respiratory Hypersensitivity drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master ...
Business Wire (press release) - Wed, 01 Jul 2015 09:41



U.S. Pays for Scientology Experiment on Sick Veterans
As it turns out, unexplained aches, pains, and fatigue are among the cluster of symptoms—along with headaches, muscle and joint pain, respiratory disorders, memory loss, and indigestion—that make up the condition commonly known as Gulf War Syndrome.
Daily Beast - Tue, 11 Aug 2015 22:02

Orexigen Announces Korean Distributorship Agreement with Kwang Dong ...
An attempt by a patient to overcome any naltrexone opioid blockade by administering large amounts of exogenous opioids is especially dangerous and may lead to a fatal overdose or life-threatening opioid intoxication (eg, respiratory arrest, circulatory ...
MarketWatch - Thu, 06 Aug 2015 03:52

European Commission Grants Marketing Authorisation for Unituxin™ (dinutuximab ...
The most frequently occurring (more than 30% of patients) adverse reactions reported during the neuroblastoma studies were hypotension (67%), pain (66%), hypersensitivity (56%), pyrexia (53%), urticaria (49%), capillary leak syndrome (45%), anaemia (45 ...
PR Newswire (press release) - Mon, 17 Aug 2015 03:02

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and ...
JANUVIA is contraindicated in patients with a history of a serious hypersensitivity reaction to sitagliptin, such as anaphylaxis or angioedema. There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with ...
Business Wire (press release) - Thu, 20 Aug 2015 05:22

BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS ...
The most serious adverse reactions associated with all opioids, including ONSOLIS, are respiratory depression (potentially leading to apnea or respiratory arrest), circulatory depression, hypotension, and shock. Follow all patients for symptoms of ...
PR Newswire (press release) - Thu, 13 Aug 2015 04:03

New Analysis Reports Lower Rates of Serious Cardio-Respiratory Events Among ...
Fluzone High-Dose vaccine should not be administered to anyone with a known hypersensitivity (eg, anaphylaxis) to any vaccine component, including egg protein, or to a previous dose of any influenza vaccine. If Guillain-Barre syndrome has occurred ...
PR Newswire (press release) - Mon, 03 Aug 2015 05:04



Myrbetriq Gains New Contraindication, Warning
The new label now includes a contraindication for patients who have known hypersensitivity reactions to mirabegron or any component of the tablet. Also, the label includes a warning regarding angioedema of the face, lips, tongue, and/or larynx. ... of ...
Monthly Prescribing Reference (registration) - Wed, 12 Aug 2015 09:07


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014